Establishing a bronchiectasis patient registry in China
Official title: The Establishment of China Bronchiectasis Registry and the Optimal Treatment Research Collaboration for Bronchiectasis (BEChina)
Run by Shanghai Pulmonary Hospital, Shanghai, China · NCT03643653 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is creating a patient registry for people with bronchiectasis in China to gather information that can help improve treatment and understanding of the disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Shanghai Pulmonary Hospital, Shanghai, China Academic / other |
| Locations | 2 sites (Shanghai, Shanghai and 1 other locations) |
| Trial ID | NCT03643653 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are patients diagnosed with bronchiectasis who are willing to participate and provide necessary medical information.
✕Probably not a fit
Patients under 18 years old or those with incomplete essential medical information will not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This initiative aims to create a multi-centered registry for patients with bronchiectasis across China, starting with three teaching hospitals in Shanghai. The registry will collect detailed patient information and follow-up data to enhance understanding of the disease's prognosis. It will also facilitate the initiation of optimal treatment studies based on the collected data. The project seeks to promote clinical research and education in bronchiectasis through collaboration and sharing of expertise among participating institutions.
Why it matters
Potential benefit: If successful, this registry could lead to improved understanding and management of bronchiectasis in patients across China.
How similar studies have gone: While this approach is novel in China, similar registries in other countries have shown success in improving patient outcomes and advancing research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with bronchiectasis according to 'non-cystic fibrosis bronchiectasis guideline' published by British Thoracic Society in 2010. * Patients who are willing to sign the consent form and participate in the study. Exclusion Criteria: * Patients with incomplete essential information, which is needed for the integrity of data analysis. Essential information include CT images, respiratory sample cultures, spirometry and exacerbation history for at least one year. * Patients under 18 years old.
Where it's running
-
Shanghai Pulmonary Hospital , Tongji University
Shanghai, Shanghai, China Recruiting -
Ruijin Hospital
Shanghai, China Recruiting
Study contacts
- Study coordinator: Jin-Fu Xu, MD
- Email: jfxucn@163.com
- Phone: +86-13321922898
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
Breathlessness in respiratory diseases: who feels it and why
This study tests how physiology, psychology, function, and breathing patterns relate to breathlessness in people with respiratory conditions compared with healthy controls.
-
Hypertonic saline inhalation for NTM lung disease
This trial tests whether starting inhaled 3% hypertonic saline early helps people with non-tuberculous mycobacterial lung disease feel better and clear bacteria better, compared with starting with normal saline first.
-
Azithromycin added to usual care to see if it lowers bronchiectasis flare-ups
This trial tests whether taking azithromycin daily for a year reduces bronchiectasis-related flare-ups in adults with non-cystic fibrosis bronchiectasis.
-
Bronchiectasis Phenotype Identification Model for Adults
This study tests a baseline classifier to categorize adults with non-cystic fibrosis bronchiectasis into phenotype groups using data collected over time.
-
BASE: Aiming to test a simple, objective way to gauge bronchiectasis severity and predict flare-ups
This study tests a new BASE framework to classify how severe non-cystic fibrosis bronchiectasis is right now and see if it can predict 12 months of worsening or flare-ups.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.